Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-65,853
Closed -$4.44M 46
2025
Q3
$4.44M Sell
65,853
-5,661
-8% -$376K 0.53% 62
2025
Q2
$4.66M Buy
71,514
+16,894
+31% +$1.01M 0.53% 65
2025
Q1
$3.37M Sell
54,620
-105,871
-66% -$7.01M 0.38% 71
2024
Q4
$11.6M Buy
160,491
+27,786
+21% +$2.17M 1.28% 35
2024
Q3
$10.8M Buy
132,705
+4,068
+3% +$325K 1.13% 36
2024
Q2
$9.55M Buy
128,637
+1,017
+0.8% +$76.2K 1.07% 39
2024
Q1
$9.95M Buy
127,620
+53,545
+72% +$3.98M 1.09% 41
2023
Q4
$5.29M Buy
+74,075
New +$5.16M 0.66% 60

Other funds holding HOLX

Prospector Partners's HOLX Position: Q4 2025 in Review

Prospector Partners sold out of Hologic (HOLX) in Q4 2025, closing a stake of 65,853 shares — an estimated $4.44M sold.

Prospector Partners first reported a position in HOLX in Q4 2023 and held it in 8 quarters. The position peaked at $11.6M in Q4 2024. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

  • Prospector Partners reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
  • Prospector Partners sold 65,853 Hologic shares in Q4 2025, an estimated $4.44M.
  • Prospector Partners first reported a position in Hologic in Q4 2023 and held it in 8 quarters.
  • Prospector Partners's Hologic position peaked at $11.6M in Q4 2024.
  • 749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on Prospector Partners's 13F filing for Q4 2025, filed 13 Feb 2026.